Prisma Health - Infectious Diseases - Greenville — Greenville, South Carolina

Prisma Health - Infectious Diseases - Greenville is a clinical research site located in Greenville, South Carolina, United States 29605.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Prisma Health - Infectious Diseases - Greenville has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC).

Sponsors: Innoviva Specialty Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Greenville

Browse all research sites in South Carolina · View every site in Greenville

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Prisma Health - Infectious Diseases - Greenville?

Prisma Health - Infectious Diseases - Greenville has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Prisma Health - Infectious Diseases - Greenville conducted?

Prisma Health - Infectious Diseases - Greenville has 1 clinical trials on record, with 1 currently active. Their work covers Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC).

Is Prisma Health - Infectious Diseases - Greenville accredited by Crixeo Clinical Trials?

Prisma Health - Infectious Diseases - Greenville has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Prisma Health - Infectious Diseases - Greenville?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.